November 2, 2021

The first prescription drug Viagra for women is under FDA approval

Your libido could be boosted this week. This week, flibanserin (rhymes with “vagina”) is subject to FDA approval for the third time, with lawmakers and a grassroots support effort in force.

The first two rejections were severe – the FDA approval committee refused to market a drug that offered only modest benefits and whose side effects (drowsiness, nausea, drowsiness – the usual nightmare trifecta) were more important than the drug itself.

Unlike Viagra, which shows an immediate effect (ahem), flibanserin has to be taken over a longer period of time and becomes more effective in regular doses. Basically, it will require some foreplay from your body, but promises to work for a longer period of time to improve female libido. It would be quite a revolutionary drug to enter the market, considering that there are currently over 20 male sexual enhancement drugs on the market … and

zero

for women.

Sprout Pharmaceuticals, the creator of flibanserin, sponsors the Even the Score media campaign, designed to promote equity in women’s sexual health. They raised awareness of the serious lack of pharmaceutical options for women with sexual dysfunction and partnered with Terry O’Neill, President of NOW (National Organization for Women), to speak out against the gender biases inherent in pharmaceutical drugs that enhance sexuality. .

The truth is, female sexual pleasure has been largely ignored by lawmakers and even science for most of history, so the fact that science AND law come together to discuss our natural right to bodily pleasure is a minor success in itself. All women deserve the right to a positive and enjoyable sexual experience.

If flibanserin isn’t the drug to deliver it, then another will. Lorexys, a non-hormonal oral drug, has been accelerated by the FDA for an expedited testing route because it is composed of antidepressants already on the market and approved by the administration.

UPDATE 5:30 p.m .: The New York Times Reports that the FDA voted 18-6 in the recommendation to approve flibanserin. “Everyone who voted yes said approval should only come if certain steps are taken to reduce the risk of side effects,” he added. Times said.

Hoping the benefits outweigh the side effects this time around. Highlights for everyone!


Source link